| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |